Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer Related Lymphedema With Early Equipment Supplied In Europe
12 equipment items found
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with approximately 1.9 million new cases in 2020. In Germany ...
Manufactured by:Oxford Vacmedix UK Limited based inOxford, UNITED KINGDOM
Tumours can often avoid being targeted by these T Cells by looking like a cell found normally in the body often referred to as “self”. If a group of T Cells can be encouraged to recognise these tumours as foreign and not self then they will attack the tumour and provide an effective treatment against it. Injecting a preparation that stimulates these T Cells effectively vaccinates the ...
Manufactured by:Micrima Limited based inBristol, UNITED KINGDOM
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is mammography, which has limitations in women with dense breasts. MARIA® scans, with non-ionising radiation, increases the frequency women can be scanned ...
Manufactured by:Abviris Deutschland GmbH based inAhrensburg, GERMANY
Innovative solutions for the serological detection of HPV16 induced cancer. From a diagnostics point of view it is irrelevant to detect the very common HPV infections but rather important to identify HPV induced deseases. The presence of increased HPV16 L1 antibodies is a highly specific indicator for altered cells in patients which have not been vaccinated against HPV. An elevated level of these ...
Manufactured by:Rarecells Diagnostics SAS based inParis Cedex 06, FRANCE
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the primary cause of 90% of all cancer-related deaths. Circulating Tumor Cells (CTCs) detection and analysis are the foundation of non-invasive tests ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Toumai™ Endoscopic Surgery Robot successfully completed its First-In-Man (FIM) trial for Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) at Shanghai Oriental Hospital on November 1st 2019. Under the guidance of Academician Sun Yinghao, RALRP was provided to a 65 year old local patient, who was admitted to the hospital for early prostate cancer, the whole surgery lasted 1.5 hours. ...
Manufactured by:InSphero AG based inSchlieren, SWITZERLAND
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of artificial matrices. Ideal for early stage cancer drug efficacy testing and screening appliciations, these advanced cancer models help bridge the gap between ...
Manufactured by:Amadix based inValladolid, SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal Cancer (CRC) and advanced adenoma (AA). Prevecol identifies molecular biomarkers in blood, with ...
Manufactured by:Therawis based inMunich, GERMANY
Personalized medicine aims to identify patients who require treatment and subsequently select the right therapy based on individual factors and tumor characteristics, i.e. personalized medicine targets to identify the right patients for the right therapy. Prognostic biomarkers provide information on the risk of disease recurrence whereby predictive ones will inform the physician of the potential ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...